These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32936523)

  • 21. Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world.
    Frentz D; Boucher CA; van de Vijver DA
    AIDS Rev; 2012; 14(1):17-27. PubMed ID: 22297501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of WHO transmitted drug resistance mutations by deep sequencing in antiretroviral-naïve subjects in Hunan Province, China.
    Xiaobai Z; Xi C; Tian H; Williams AB; Wang H; He J; Zhen J; Chiarella J; Blake LA; Turenchalk G; Kozal MJ
    PLoS One; 2014; 9(6):e98740. PubMed ID: 24896087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transmitted HIV Drug Resistance Is High and Longstanding in Metropolitan Washington, DC.
    Kassaye SG; Grossman Z; Balamane M; Johnston-White B; Liu C; Kumar P; Young M; Sneller MC; Sereti I; Dewar R; Rehm C; Meyer W; Shafer R; Katzenstein D; Maldarelli F
    Clin Infect Dis; 2016 Sep; 63(6):836-843. PubMed ID: 27307507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug Resistance Mutations in a Population Before Antiretroviral Therapy Initiation in Northern South Africa.
    Ogola B; Matume ND; Mavhandu-Ramarumo LG; Tebit DM; Bessong PO
    AIDS Res Hum Retroviruses; 2022 Mar; 38(3):248-256. PubMed ID: 34107774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low prevalence of transmitted HIV type 1 drug resistance among antiretroviral-naive adults in a rural HIV clinic in Kenya.
    Hassan AS; Mwaringa SM; Obonyo CA; Nabwera HM; Sanders EJ; Rinke de Wit TF; Cane PA; Berkley JA
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):129-35. PubMed ID: 22900472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population dynamics of HIV drug resistance during treatment scale-up in Uganda: a population-based longitudinal study.
    Martin MA; Reynolds SJ; Foley BT; Nalugoda F; Quinn TC; Kemp SA; Nakalanzi M; Kankaka EN; Kigozi G; Ssekubugu R; Gupta RK; Abeler-Dörner L; Kagaayi J; Ratmann O; Fraser C; Galiwango RM; Bonsall D; Grabowski MK
    medRxiv; 2024 Oct; ():. PubMed ID: 39417110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmitted antiretroviral drug resistance in individuals with newly diagnosed HIV infection: South Carolina 2005-2009.
    Youmans E; Tripathi A; Albrecht H; Gibson JJ; Duffus WA
    South Med J; 2011 Feb; 104(2):95-101. PubMed ID: 21206421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of transmitted drug resistance among ART-naïve HIV-infected individuals, Beijing, 2015-2018.
    Li R; Song C; Chen D; Li C; Hao Y; Zeng H; Han J; Zhao H
    J Glob Antimicrob Resist; 2022 Mar; 28():241-248. PubMed ID: 35092830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. National prevalence and trends of HIV transmitted drug resistance in Mexico.
    Avila-Ríos S; García-Morales C; Garrido-Rodríguez D; Ormsby CE; Hernández-Juan R; Andrade-Villanueva J; González-Hernández LA; Torres-Escobar I; Navarro-Álvarez S; Reyes-Terán G;
    PLoS One; 2011; 6(11):e27812. PubMed ID: 22110765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.
    Hofstra LM; Sauvageot N; Albert J; Alexiev I; Garcia F; Struck D; Van de Vijver DAMC; Åsjö B; Beshkov D; Coughlan S; Descamps D; Griskevicius A; Hamouda O; Horban A; Van Kasteren M; Kolupajeva T; Kostrikis LG; Liitsola K; Linka M; Mor O; Nielsen C; Otelea D; Paraskevis D; Paredes R; Poljak M; Puchhammer-Stöckl E; Sönnerborg A; Staneková D; Stanojevic M; Van Laethem K; Zazzi M; Zidovec Lepej S; Boucher CAB; Schmit JC; Wensing AMJ; ; Puchhammer-Stockl E; Sarcletti M; Schmied B; Geit M; Balluch G; Vandamme AM; Vercauteren J; Derdelinckx I; Sasse A; Bogaert M; Ceunen H; De Roo A; De Wit S; Echahidi F; Fransen K; Goffard JC; Goubau P; Goudeseune E; Yombi JC; Lacor P; Liesnard C; Moutschen M; Pierard D; Rens R; Schrooten Y; Vaira D; Vandekerckhove LPR; Van den Heuvel A; Van Der Gucht B; Van Ranst M; Van Wijngaerden E; Vandercam B; Vekemans M; Verhofstede C; Clumeck N; Van Laethem K; Beshkov D; Alexiev I; Lepej SZ; Begovac J; Kostrikis L; Demetriades I; Kousiappa I; Demetriou V; Hezka J; Linka M; Maly M; Machala L; Nielsen C; Jørgensen LB; Gerstoft J; Mathiesen L; Pedersen C; Nielsen H; Laursen A; Kvinesdal B; Liitsola K; Ristola M; Suni J; Sutinen J; Descamps D; Assoumou L; Castor G; Grude M; Flandre P; Storto A; Hamouda O; Kücherer C; Berg T; Braun P; Poggensee G; Däumer M; Eberle J; Heiken H; Kaiser R; Knechten H; Korn K; Müller H; Neifer S; Schmidt B; Walter H; Gunsenheimer-Bartmeyer B; Harrer T; Paraskevis D; Hatzakis A; Zavitsanou A; Vassilakis A; Lazanas M; Chini M; Lioni A; Sakka V; Kourkounti S; Paparizos V; Antoniadou A; Papadopoulos A; Poulakou G; Katsarolis I; Protopapas K; Chryssos G; Drimis S; Gargalianos P; Xylomenos G; Lourida G; Psichogiou M; Daikos GL; Sipsas NV; Kontos A; Gamaletsou MN; Koratzanis G; Sambatakou H; Mariolis H; Skoutelis A; Papastamopoulos V; Georgiou O; Panagopoulos P; Maltezos E; Coughlan S; De Gascun C; Byrne C; Duffy M; Bergin C; Reidy D; Farrell G; Lambert J; O'Connor E; Rochford A; Low J; Coakely P; O'Dea S; Hall W; Mor O; Levi I; Chemtob D; Grossman Z; Zazzi M; de Luca A; Balotta C; Riva C; Mussini C; Caramma I; Capetti A; Colombo MC; Rossi C; Prati F; Tramuto F; Vitale F; Ciccozzi M; Angarano G; Rezza G; Kolupajeva T; Vasins O; Griskevicius A; Lipnickiene V; Schmit JC; Struck D; Sauvageot N; Hemmer R; Arendt V; Michaux C; Staub T; Sequin-Devaux C; Wensing AMJ; Boucher CAB; van de Vijver DAMC; van Kessel A; van Bentum PHM; Brinkman K; Connell BJ; van der Ende ME; Hoepelman IM; van Kasteren M; Kuipers M; Langebeek N; Richter C; Santegoets RMWJ; Schrijnders-Gudde L; Schuurman R; van de Ven BJM; Åsjö B; Kran AB; Ormaasen V; Aavitsland P; Horban A; Stanczak JJ; Stanczak GP; Firlag-Burkacka E; Wiercinska-Drapalo A; Jablonowska E; Maolepsza E; Leszczyszyn-Pynka M; Szata W; Camacho R; Palma C; Borges F; Paixão T; Duque V; Araújo F; Otelea D; Paraschiv S; Tudor AM; Cernat R; Chiriac C; Dumitrescu F; Prisecariu LJ; Stanojevic M; Jevtovic D; Salemovic D; Stanekova D; Habekova M; Chabadová Z; Drobkova T; Bukovinova P; Shunnar A; Truska P; Poljak M; Lunar M; Babic D; Tomazic J; Vidmar L; Vovko T; Karner P; Garcia F; Paredes R; Monge S; Moreno S; Del Amo J; Asensi V; Sirvent JL; de Mendoza C; Delgado R; Gutiérrez F; Berenguer J; Garcia-Bujalance S; Stella N; de Los Santos I; Blanco JR; Dalmau D; Rivero M; Segura F; Elías MJP; Alvarez M; Chueca N; Rodríguez-Martín C; Vidal C; Palomares JC; Viciana I; Viciana P; Cordoba J; Aguilera A; Domingo P; Galindo MJ; Miralles C; Del Pozo MA; Ribera E; Iribarren JA; Ruiz L; de la Torre J; Vidal F; Clotet B; Albert J; Heidarian A; Aperia-Peipke K; Axelsson M; Mild M; Karlsson A; Sönnerborg A; Thalme A; Navér L; Bratt G; Karlsson A; Blaxhult A; Gisslén M; Svennerholm B; Bergbrant I; Björkman P; Säll C; Mellgren Å; Lindholm A; Kuylenstierna N; Montelius R; Azimi F; Johansson B; Carlsson M; Johansson E; Ljungberg B; Ekvall H; Strand A; Mäkitalo S; Öberg S; Holmblad P; Höfer M; Holmberg H; Josefson P; Ryding U
    Clin Infect Dis; 2016 Mar; 62(5):655-663. PubMed ID: 26620652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance at virological failure using boosted protease inhibitors versus nonnucleoside reverse transcriptase inhibitors as first-line antiretroviral therapy--implications for sustained efficacy of ART in resource-limited settings.
    Hill A; McBride A; Sawyer AW; Clumeck N; Gupta RK
    J Infect Dis; 2013 Jun; 207 Suppl 2():S78-84. PubMed ID: 23687293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low prevalence of transmitted drug resistance of HIV-1 during 2008-2012 antiretroviral therapy scaling up in Southern Vietnam.
    Tanuma J; Quang VM; Hachiya A; Joya A; Watanabe K; Gatanaga H; Van Vinh Chau N; Chinh NT; Oka S
    J Acquir Immune Defic Syndr; 2014 Aug; 66(4):358-64. PubMed ID: 24815852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 drug resistance surveillance in antiretroviral treatment-naive individuals from a reference hospital in Guatemala, 2010-2013.
    Avila-Ríos S; García-Morales C; Garrido-Rodríguez D; Tapia-Trejo D; Girón-Callejas AC; Mendizábal-Burastero R; Escobar-Urias IY; García-González BL; Navas-Castillo S; Pinzón-Meza R; Mejía-Villatoro CR; Reyes-Terán G
    AIDS Res Hum Retroviruses; 2015 Apr; 31(4):401-11. PubMed ID: 25347163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population.
    Rhee SY; Clutter D; Fessel WJ; Klein D; Slome S; Pinsky BA; Marcus JL; Hurley L; Silverberg MJ; Kosakovsky Pond SL; Shafer RW
    Clin Infect Dis; 2019 Jan; 68(2):213-221. PubMed ID: 29846534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic.
    Pineda-Peña AC; Schrooten Y; Vinken L; Ferreira F; Li G; Trovão NS; Khouri R; Derdelinckx I; De Munter P; Kücherer C; Kostrikis LG; Nielsen C; Littsola K; Wensing A; Stanojevic M; Paredes R; Balotta C; Albert J; Boucher C; Gomez-Lopez A; Van Wijngaerden E; Van Ranst M; Vercauteren J; Vandamme AM; Van Laethem K
    PLoS One; 2014; 9(7):e101738. PubMed ID: 25003369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of transmitted HIV-1 drug resistance among treatment-naive individuals in China, 2000-2016.
    Yuan H; Liu Z; Wu X; Wu M; Fang Q; Zhang X; Shi T; Tully DC; Zhang T
    Arch Virol; 2021 Sep; 166(9):2451-2460. PubMed ID: 34195923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transmitted drug resistance and transmission clusters among HIV-1 treatment-naïve patients in Guangdong, China: a cross-sectional study.
    Lan Y; Li L; He X; Hu F; Deng X; Cai W; Li J; Ling X; Fan Q; Cai X; Li L; Li F; Tang X
    Virol J; 2021 Sep; 18(1):181. PubMed ID: 34488793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in HIV-1 pretreatment drug resistance and HIV-1 variant dynamics among antiretroviral therapy-naive Ethiopians from 2003 to 2018: a pooled sequence analysis.
    Kiros M; Biset S; Gebremariam B; Yalew GT; Abegaz WE; Geteneh A
    Virol J; 2023 Oct; 20(1):243. PubMed ID: 37880705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global estimates of HIV infections and AIDS cases: 1991.
    Chin J
    AIDS; 1991; 5 Suppl 2():S57-61. PubMed ID: 1845061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stable level of HIV transmitted drug resistance in Estonia despite significant scale-up of antiretroviral therapy.
    Soodla P; Huik K; Pauskar M; Cuypers L; Van Laethem K; Rajasaar H; Kallas E; Lepa H; Velts-Lindh A; Jõgeda EL; Lutsar I; Avi R
    Infect Genet Evol; 2019 Nov; 75():103901. PubMed ID: 31146045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.